New marker of drug response may speed pace of lung cancer prevention trials
January 8, 2013 · Comments Off
Testing medicines to prevent lung cancer requires treating many thousands of high-risk individuals and then waiting 5, 10 or 15 years for results. A possible waypoint on the way to benefit may dramatically speed testing.
Serendipity points to new potential target and therapy for melanoma
December 20, 2012 · 2 comments
MicroRNA can decide which genes in a cell's DNA are expressed and which stay silent. Melanoma tends to lack microRNA-26a, which makes the gene SODD go silent. This silence creates cancer and may be instrumental in its cure.
MicroRNA-218 targets medulloblastoma, most aggressive childhood brain cancer
December 12, 2012 · Comments Off
In medulloblastoma, a malignant brain tumor of children, microRNA-218 is especially low and by adding microRNA-218 to cells engineered to develop medulloblastoma, the development of the disease stopped.
MicroRNA makes triple-negative breast cancer homesick
November 21, 2012 · Comments Off
Like a sea monster, the programmed cell death known as anoikis attacks unprepared travelers -- in this case, cancer cells during metastasis
The making and unmaking of stem-like, aggressive breast cancer cells
August 9, 2012 · Comments Off
Breast cancers that depend on the hormones estrogen and progesterone are susceptible to treatments targeting...
New grant funds collaborative effort to develop accurate, easy test to detect recurrence of ovarian cancer
October 17, 2011 · Comments Off
The current test for the recurrence of ovarian cancer after treatment requires a blood draw...
NTRK1: a new oncogene and target in lung cancer
October 17, 2011
alk drug lung cancer amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno arnold levinson biomarkers bladder cancer breast cancer cancer grants cancer research colorado Cancer Survivorship CICL clinical trial colorado cancer benefit colorectal cancer crizotinib Dan Theodorescu fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma metastasis microRNA Monique Spillman paul bunn prostate cancer publications rajesh agarwal ross camidge screening skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith